Category: Women's Health
Women's Health market research reports by GlobalData
-
France Myomectomy Procedures Count by Segments (Robotic Myomectomy Procedures and Non-Robotic Myomectomy Procedures) and Forecast to 2030
France Myomectomy Procedures Count by Segments (Robotic Myomectomy Procedures and Non-Robotic Myomectomy Procedures) and Forecast to 2030 Summary GlobalData’s “France Myomectomy Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the France Myomectomy Proc ... Read More
-
Brazil Hysterectomy Procedures Count by Segments (Robotic Hysterectomy Procedures and Non-Robotic Hysterectomy Procedures) and Forecast to 2030
Brazil Hysterectomy Procedures Count by Segments (Robotic Hysterectomy Procedures and Non-Robotic Hysterectomy Procedures) and Forecast to 2030 Summary GlobalData’s “Brazil Hysterectomy Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Brazil Hystere ... Read More
-
Femtech (Women's Health) - Thematic Intelligence
Femtech (Women's Health) - Thematic Intelligence Summary Women's health has long been neglected and underfunded, leading to significant unmet needs, lack of investment and innovation, and a disparity in access to care for female-specific health issues. One area where this is particularly pronounced ... Read More
-
HER2 Amplification Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033
HER2 Amplification Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033 Summary HER2 Amplification Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impa ... Read More
-
Human Papilloma Virus Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033
Human Papilloma Virus Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033 Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Marke ... Read More
-
Endometriosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
Endometriosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030 Summary The endometriosis market is currently highly genericized and contains many off-label medications, su ... Read More
-
Digital Marketing Trends in Breast Cancer
Digital Marketing Trends in Breast Cancer Summary Between November 2021 and October 2022, Merck & Co’s Keytruda.com achieved the highest traffic among branded breast cancer patient sites in the US with almost 4.8 million visitors, followed by Eli Lilly’s Verzenio.com (4.4 million visits). The highes ... Read More
-
Polycystic Ovarian Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Polycystic Ovarian Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Polycystic Ovarian Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts ... Read More
-
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HER2- Breast Cancer therapeutics. Synopsis In 2022, there will be more than one million incide ... Read More
-
Uterine Leiomyoma (Uterine Fibroids) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Uterine Leiomyoma (Uterine Fibroids) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Uterine Leiomyoma (Uterine Fibroids) - Global Clinical Trials Review, 2022 provides a ... Read More
-
Reversible Contraceptive Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030
Reversible Contraceptive Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 Summary Reversible Contraceptive Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Anal ... Read More
-
Vulvovaginal Candidiasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Vulvovaginal Candidiasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Vulvovaginal Candidiasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End ... Read More
-
Triple-Negative Breast Cancer (TNBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Triple-Negative Breast Cancer (TNBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Triple-Negative Breast Cancer (TNBC) Clinical Trial Analysis by Trial Phase, Trial St ... Read More
-
Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sp ... Read More
-
Cervical Cancer Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
Cervical Cancer Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030 Summary Cervical cancer is the second most common cancer in women under the age of 45: Chronic infection with high-risk onc ... Read More
-
Cervical Cancer - Epidemiology Forecast to 2030
Cervical Cancer - Epidemiology Forecast to 2030 Summary Cervical cancer is a type of cancer that occurs in the cells of the cervix, which connects the vagina (birth canal) to the upper part of the uterus (Mayo Clinic, 2021). All women are at risk for cervical cancer. It occurs most often in women ag ... Read More
Research Assistance
